DekaBank Deutsche Girozentrale’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,917
Closed -$394K 1493
2021
Q3
$394K Hold
5,917
﹤0.01% 1101
2021
Q2
$638K Sell
5,917
-5,833
-50% -$691K ﹤0.01% 1015
2021
Q1
$1.68M Buy
11,750
+10,417
+781% +$1.69M 0.01% 749
2020
Q4
$228K Hold
1,333
﹤0.01% 1164
2020
Q3
$213K Buy
+1,333
New +$269K ﹤0.01% 1042

Other funds holding TECX

DekaBank Deutsche Girozentrale's TECX Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 5,917 shares — an estimated $394K sold.

DekaBank Deutsche Girozentrale first reported a position in TECX in Q3 2020 and held it in 5 quarters. The position peaked at $1.68M in Q1 2021. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 5,917 Tectonic Therapeutic shares in Q4 2021, an estimated $394K.
  • DekaBank Deutsche Girozentrale first reported a position in Tectonic Therapeutic in Q3 2020 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's Tectonic Therapeutic position peaked at $1.68M in Q1 2021.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.